Therapy News and Research

RSS

NeuroDerm signs definitive investment agreements for $16 million financing round

NeuroDerm Ltd., a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) diseases, today announced that it has signed definitive investment agreements for a $16 million financing round led by certain of its existing investors with the participation of new investors, including The Elias Group.

21 Aug 2014

Erlotinib feasible in KRAS wild-type lung adenocarcinoma

Erlotinib is a valid treatment option for patients with KRAS wild-type lung adenocarcinoma refractory to chemotherapy, study data show.

21 Aug 2014

Investigational drug focuses on slowing Alzheimer's disease progression

Patients with mild to moderate Alzheimer's disease currently have no treatment options to slow brain cell deterioration. Researchers at Houston Methodist's Nantz National Alzheimer Center are studying an investigational drug that proposes to do just that.

21 Aug 2014

Cognitive therapy combined with antidepressant drug effective for severe nonchronic depression

The odds that a person who suffers from severe, nonchronic depression will recover are improved by as much as 30 percent if they are treated with a combination of cognitive therapy and antidepressant medicine rather than by antidepressants alone.

21 Aug 2014

Blocking nerve signals could be effective treatment for stomach cancer

Research from Columbia University Medical Center shows that nerves may play a critical role in stomach cancer growth and that blocking nerve signals using surgery or Botox® (onabotulinumtoxinA) could be an effective treatment for the disease.

21 Aug 2014

New gene therapy protects mice from life-threatening heart condition

A new gene therapy developed by researchers at the University of Missouri School of Medicine has been shown to protect mice from a life-threatening heart condition caused by muscular dystrophy.

21 Aug 2014

Newborn screening for SCID holds promise that affected children can lead healthy lives

Using population-based screening outcomes of approximately 3 million infants, a team of scientists across 14 states, including four researchers at the University of Massachusetts Medical School, have shown that newborn screening for severe combined immunodeficiency (SCID) can be successfully implemented across public health newborn screening programs.

21 Aug 2014

Regular blood transfusion therapy reduces recurrence of strokes in kids with sickle cell anemia

Vanderbilt-led research, as part of an international, multicenter trial, found regular blood transfusion therapy significantly reduces the recurrence of silent strokes and strokes in children with sickle cell anemia who have had pre-existing silent strokes, according to study results released today in the New England Journal of Medicine (NEJM).

21 Aug 2014

Study identifies protein that appears to play key role in protecting people infected with tuberculosis

UCLA-led study has identified a protein that appears to play a key role in protecting people infected with Mycobacterium tuberculosis — the bacterium that causes tuberculosis — from developing the active form of the disease.

21 Aug 2014

FDA approves GlaxoSmithKline’s Arnuity Ellipta for treatment of asthma

GlaxoSmithKline plc today announced that the FDA has approved Arnuity™ Ellipta® (fluticasone furoate inhalation powder), a once-daily inhaled corticosteroid (ICS) medicine for maintenance treatment of asthma as prophylactic therapy in patients aged 12 years and older. Arnuity is not indicated for relief of acute bronchospasm.

21 Aug 2014

Study identifies best course of treatment for endophthalmitis

The most common cause of endophthalmitis, a potentially blinding condition that can occur after eye trauma, eye surgery, and eye injections, are the well-known staphylococci ("staph") and streptococci ("strep") bacterial strains, according to a study published in the August issue of Ophthalmology and based on a review of 25 years of cases at New York Eye and Ear Infirmary of Mount Sinai (NYEE).

21 Aug 2014

Early intervention hope for childhood achromatopsia

Researchers have found that children with achromatopsia have milder foveal pathology than their older counterparts, highlighting a potential opportunity for early intervention with gene therapy.

20 Aug 2014

CD157 important in malignant pleural mesothelioma

CD157 plays a pivotal role in the progression of malignant pleural mesothelioma and may be useful in the stratification of patients into different prognostic groups, Italian research suggests.

20 Aug 2014

Using a nanotech microchip to diagnose type 1 diabetes: an interview with Dr. Brian Feldman, Stanford School of Medicine

The most common form of diabetes is sometimes referred to as metabolic diabetes, which is the diabetes most people are very familiar with, type 2 diabetes. This form of diabetes is most prevalent in people that are overweight or obese. Historically, it has been confined to adults or older patients but it has been on the rise as the global obesity problem has continued to worsen.

20 Aug 2014

Sheffield Teaching Hospitals begins treating wet AMD patients with Oraya Therapy

SHEFFIELD Teaching Hospitals NHS Foundation Trust has become the first NHS hospital in the UK to start offering its patients a new non-invasive treatment for wet age-related macular degeneration (wet AMD).

20 Aug 2014

Physicians of Orthopaedic & Spine Center open new Pain Management Center at Virginia

The physicians of Orthopaedic & Spine Center have announced the opening of their new Pain Management Center, located at 250 Nat Turner Boulevard in Newport News, Virginia. In its sixth year, the pain management program now has its own dedicated space on the second floor.

20 Aug 2014

Longitude and NovaQuest acquire California Cryobank

California Cryobank, a global leader in reproductive tissue donor services and storage and stem cell banking, announced today that it has been acquired by equity investors Longitude Venture Partners II, L.P. and NovaQuest Pharma Opportunities Fund III, L.P..

20 Aug 2014

Analysis of Candida glabrata fungus mutations reveals new genes that confer anti-fungal tolerance

A group of researchers at the Max F. Perutz Laboratories has created one of the three world's largest gene libraries for the Candida glabrata yeast, which is harmful to humans.

20 Aug 2014

Study measures quality indicators in cardiac rehabilitation programs across Canada

The quality of cardiac rehabilitation programs across Canada is strong, with specific criteria areas now identified as requiring further enhancement to improve patient outcomes, according to a new study conducted by researchers at the Peter Munk Cardiac Centre, York University and UHN.

20 Aug 2014

Study examines national impact of newborn screening test for SCID

Severe combined immunodeficiency (SCID), a potentially life-threatening, but treatable, disorder affecting infants, is twice as common as previously believed, according to a new study that is the first to examine the national impact of this newborn screening test.

20 Aug 2014

Therapy News and Research

NeuroDerm signs definitive investment agreements for $16 million financing round

Erlotinib feasible in KRAS wild-type lung adenocarcinoma

Investigational drug focuses on slowing Alzheimer's disease progression

Cognitive therapy combined with antidepressant drug effective for severe nonchronic depression

Blocking nerve signals could be effective treatment for stomach cancer

New gene therapy protects mice from life-threatening heart condition

Newborn screening for SCID holds promise that affected children can lead healthy lives

Regular blood transfusion therapy reduces recurrence of strokes in kids with sickle cell anemia

Study identifies protein that appears to play key role in protecting people infected with tuberculosis

FDA approves GlaxoSmithKline’s Arnuity Ellipta for treatment of asthma

Study identifies best course of treatment for endophthalmitis

Early intervention hope for childhood achromatopsia

CD157 important in malignant pleural mesothelioma

Using a nanotech microchip to diagnose type 1 diabetes: an interview with Dr. Brian Feldman, Stanford School of Medicine

Sheffield Teaching Hospitals begins treating wet AMD patients with Oraya Therapy

Physicians of Orthopaedic & Spine Center open new Pain Management Center at Virginia

Longitude and NovaQuest acquire California Cryobank

Analysis of Candida glabrata fungus mutations reveals new genes that confer anti-fungal tolerance

Study measures quality indicators in cardiac rehabilitation programs across Canada

Study examines national impact of newborn screening test for SCID

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News